Serum GDF9 and BMP15 as Markers of Ovarian Function in Healthy Women and Women with Polycystic Ovary Syndrome
Background: The oocyte-secreted factors growth differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) are key regulators of female fertility and are predominantly expressed by oocytes. Recently, methods to quantitate these proteins in serum have demonstrated diagnostic potential....
Main Authors: | Angelique H. RIEPSAMEN, Mark W. DONOGHOE, Inthrani R. INDRAN, Shelly LIEN, Leah HECHTMAN, David M. ROBERTSON, Robert B. GILCHRIST, Eu-Leong YONG, William L. LEDGER |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2022-09-01
|
Series: | Fertility & Reproduction |
Online Access: | https://www.worldscientific.com/doi/10.1142/S266131822274053X |
Similar Items
-
GDF9 and BMP15 Expressions and Fine Structure Changes During Folliculogenesis in Polycystic Ovary Syndrome
by: Meryem İlkay Karagül1, et al.
Published: (2018-02-01) -
Formation and characterization of BMP2/GDF5 and BMP4/GDF5 heterodimers
by: Gregory R. Gipson, et al.
Published: (2023-02-01) -
How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
by: Kaltsas, G, et al.
Published: (2000) -
Effects of obesity on the serum BMP15, GDF9, and kisspeptin concentrations in women of reproductive age
by: Arıkan Funda Bulut, et al.
Published: (2023-01-01) -
Quality of Life of Women with Polycystic Ovary Syndrome
by: Natalia Ligocka, et al.
Published: (2024-02-01)